Pure Hydrogen Corporation Limited (PH2) ORDINARY FULLY PAID |
Energy |
$28 |
December 2024 Quarterly Report
|
31 Jan 2025 9:08AM |
$0.095 |
$0.076 |
fallen by
20%
|
|
PH2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Delivered a hydrogen fuel cell garbage truck to Solo Resource Management.
- Secured multi-vehicle distribution partnerships expected to generate around AUD$10 million.
- Signed a Memorandum of Understanding with ETHERO Truck + Energy.
- Plans to demerge Australian natural gas assets into Eastern Gas Limited via IPO.
- Anticipating significant cash receipts from recent purchase orders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
1414 Degrees Limited (14D) ORDINARY FULLY PAID |
Industrials |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 9:07AM |
$0.022 |
$0.017 |
fallen by
22.73%
|
|
14D - Price-sensitive ASX Announcement
Full Release
Key Points
- $5.2m affordable hydrogen project is on track
- Aurora BESS continuing through approvals process
- Company fully funded for SiBox® and SiPHyRâ„¢ commercialization
- Commercial team engaging integration partners to advance customer project agreements
- SiBrick® progressing toward low-cost mass manufacturing
- General Manager - Operations appointed to enhance project delivery and operational efficiency
- SiBox remains the only thermal energy storage system proven to deliver consistent, stable, high-temperature heat
- SiPHyR technology making progress toward low-emission hydrogen production
- Successful demonstrations of SiBox capabilities
- Ongoing collaboration with international engineering firms for project development
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Orica Limited (ORI) ORDINARY FULLY PAID |
Materials |
$9,196 |
Company Secretary Appointment/Resignation
|
31 Jan 2025 9:07AM |
$17.210 |
$18.870 |
risen by
9.65%
|
|
Nexion Group Ltd (NNG) ORDINARY FULLY PAID |
Information Technology |
$4 |
NNG Continuation of Voluntary Suspension
|
31 Jan 2025 9:07AM |
$0.020 |
$0.020 |
fallen by
0%
|
|
Maximus Resources Limited (MXR) ORDINARY FULLY PAID |
Materials |
$33 |
Commencement of RC drilling at Lefroy Lithium JV
|
31 Jan 2025 9:07AM |
$0.063 |
$0.077 |
risen by
22.22%
|
|
MXR - Price-sensitive ASX Announcement
Full Release
Key Points
- A ~3,000m Reverse Circulation (RC) drill program has commenced under the Lefroy Lithium Joint Venture with KOMIR.
- The drill program includes 16 RC holes targeting spodumene-bearing pegmatites.
- Previously reported intersections at Bird Rock include significant lithium percentages.
- At Kandui, multiple spodumene-bearing pegmatites have been identified over a large target area.
- The Lefroy Lithium Project is situated on granted mining tenements in a highly prospective region.
- KOMIR will invest USD$3 million in lithium exploration to earn a 30% interest in the mineral rights.
- The RC drill program is expected to be completed within three weeks, with assay results expected shortly after.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Winsome Resources Limited (WR1) ORDINARY FULLY PAID |
Materials |
$33 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:06AM |
$0.480 |
$0.135 |
fallen by
71.88%
|
|
WR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Technical Report for Preliminary Economic Assessment of the Adina Lithium Project filed in Canada.
- Preliminary Information Statement submitted to Quebec authorities for project permitting.
- Renard Option period extended to protect Winsome shareholder value.
- Health and safety measures implemented for winter preparedness.
- Generative exploration focus maintained during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Bastion Minerals Limited (BMO) ORDINARY FULLY PAID |
Materials |
$3 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:06AM |
$0.005 |
$0.003 |
fallen by
40%
|
|
BMO - Price-sensitive ASX Announcement
Full Release
Key Points
- Bastion Minerals focuses on expanding its Canadian project portfolio.
- Acquisition of three high-grade copper assets completed.
- Continued exploration in Sweden for battery metals.
- Significant capital raise undertaken during the quarter.
- Review of lithium portfolio initiated for potential divestment.
- Cost reduction measures implemented for operations in Chile.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
VanEck Global Listed Private Credit (AUD Hedged) ETF (LEND) |
Financials |
$141 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$20.290 |
$18.460 |
fallen by
9.02%
|
|
VanEck Australian Floating Rate ETF (FLOT) |
Financials |
$763 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$24.960 |
$24.910 |
fallen by
0.20%
|
|
VanEck 10+ Year Australian Government Bond ETF (XGOV) |
Financials |
$300 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$50.940 |
$51.670 |
risen by
1.43%
|
|
VanEck Emerging Income Opportunities Active ETF (Managed Fund) (EBND) |
Financials |
$174 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$10.460 |
$10.430 |
fallen by
0.29%
|
|
VanEck Australian Corporate Bond Plus ETF (PLUS) |
Financials |
$371 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$16.990 |
$17.170 |
risen by
1.06%
|
|
VanEck 1-3 Month US Treasury Bond ETF (TBIL) |
Financials |
$145 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$53.930 |
$51.490 |
fallen by
4.52%
|
|
VanEck 5-10 Year Australian Government Bond ETF (5GOV) |
Financials |
$74 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$51.650 |
$52.920 |
risen by
2.46%
|
|
VanEck Bentham Global Capital Securities Active ETF (Managed Fund) (GCAP) |
Financials |
$29 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$8.880 |
$8.760 |
fallen by
1.35%
|
|
VanEck Australian Subordinated Debt ETF (SUBD) |
Financials |
$2,390 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$25.290 |
$25.020 |
fallen by
1.07%
|
|
VanEck 1-5 Year Australian Government Bond ETF (1GOV) |
Financials |
$21 |
Final Dividend/Distribution for period ending 31 Jan 2025
|
31 Jan 2025 9:06AM |
$51.320 |
$52.030 |
risen by
1.38%
|
|
Battery Age Minerals Ltd (BM8) ORDINARY FULLY PAID |
Materials |
$7 |
Trading Halt
|
31 Jan 2025 9:05AM |
$0.097 |
$0.057 |
fallen by
41.24%
|
|
BM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Battery Age Minerals Ltd requested a trading halt.
- The halt is pending an announcement regarding acquisition and capital raising.
- The trading halt will last until at least 4 February 2025.
- The company believes there is no reason for the trading halt to be denied.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Activex Limited (AIV) ORDINARY FULLY PAID |
Materials |
$1 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:05AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
AIV - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed a 2,416m reverse circulation drilling program at Mt Hogan Gold Mine.
- Notable gold intersections included 5m at 13 g/t Au and 1m at 50 g/t Au.
- Secured Doonkuna Rare Earth Elements tenement with significant REE potential.
- Financial position included $223,000 in cash and a $2.84 million loan facility.
- Andrew Bald resigned as Director effective November 28, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$107 |
Transformation Update Investor Presentation
|
31 Jan 2025 9:03AM |
$0.120 |
$0.110 |
fallen by
8.33%
|
|
Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$26 |
Completion of Recruitment of ACCENT Trial
|
31 Jan 2025 9:03AM |
$0.081 |
$0.066 |
fallen by
18.52%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- The company has completed planned enrolment of the ACCENT Phase 2a clinical trial
- The ACCENT trial explores the activity of narmafotinib in advanced pancreatic cancer patients
- Full recruitment has been achieved 2 months ahead of schedule
- Top-line data is planned for release mid-Q3 2025
- Total of 10 confirmed partial responses has been recorded from the initial patient cohort
- Median duration on trial for the first cohort is currently 197 days, representing a 68% improvement over historical data
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$285 |
Update - Notification of buy-back - RG8
|
31 Jan 2025 9:02AM |
$2.130 |
$1.900 |
fallen by
10.80%
|
|
Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 9:02AM |
$0.040 |
$0.031 |
fallen by
22.50%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos recorded unaudited revenue of US$2.9 million, up 71% from Q2 FY24.
- The majority of revenue was from the Hologic fFN Development Agreement.
- Lumos generated US$2.3 million from diagnostic test and custom reader development services.
- The CLIA waiver study for FebriDx began, with the first patient tested on 19 December 2024.
- Lumos secured a reimbursement rate of US$41.38 per test for FebriDx.
- The company aims to expand market opportunities significantly with the CLIA waiver.
- Lumos ended the quarter with cash reserves of US$5.5 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$413 |
Update - Notification of buy-back - VG1
|
31 Jan 2025 9:02AM |
$1.850 |
$1.660 |
fallen by
10.27%
|
|
Peel Mining Limited (PEX) ORDINARY FULLY PAID |
Materials |
$51 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 9:01AM |
$0.120 |
$0.088 |
fallen by
26.67%
|
|
PEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 2 drilling at Wagga Tank intersects very high-grade mineralisation.
- Notable intercepts include 119m at 3.17% Cu and 1.49g/t Au.
- Strong oxide and supergene-style mineralisation confirmed at shallow depths.
- Potential for adding significant new resources within open-pittable depths.
- Fieldwork commenced on the Curnamona Project.
- $3.67 million cash at bank reported at the end of the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.